Intervenciones de enfermería para el manejo de síntomas en personas con cáncer


PDF

Palabras clave

revisión sistemática
signos y síntomas
evaluación de eficacia-efectividad de intervenciones
enfermería oncológica

Cómo citar

Franco, O., & Carrillo, G. (2020). Intervenciones de enfermería para el manejo de síntomas en personas con cáncer. Revista Colombiana De Enfermería, 19(2), e023. https://doi.org/10.18270/rce.v19i2.3012

Resumen

Objetivo: describir las intervenciones de enfermería para el manejo de los síntomas en adultos con cáncer en tratamiento de intención curativa. Métodos: revisión de alcance; con el uso de descriptores en ciencias de la salud, se adelantó una búsqueda en las bases de datos Cochrane, PubMed y Biblioteca Virtual en Salud (BVS) en idiomas inglés y español en el periodo 2013-2020. Resultados: tras el proceso de búsqueda, análisis y evaluación crítica de la literatura, diecisiete publicaciones (n = 17) conformaron la muestra. Las piezas investigativas del estudio fueron agrupadas en cuatro categorías: intervenciones con el uso de tecnologías de la información y la comunicación, intervenciones personalizadas y adaptadas al individuo, medicina complementaria e intervenciones realizadas en el momento del tratamiento. Conclusión: las intervenciones de enfermería constituyen una importante herramienta para el adecuado manejo de síntomas. Existen varios tipos de intervención y diferentes mecanismos para su ejecución que facilitan el manejo de diversos síntomas, disminuyen la carga general del síntoma y fomentan el automanejo de estos.

https://doi.org/10.18270/rce.v19i2.3012
PDF

Referencias

1. Vijay BY. Percepciones sobre el cáncer: el impacto social, psicológico y económico del cáncer [Internet]. City of Hope; 2016 [citado 2020 abr. 25]. Disponible en: https://www.cityofhope.org/espanol/social-psychological-and-financial-impact-of-cancer
2. International Agency for Research on Cancer. Latest global cancer data: Cancer burden rises to 18.1 million new cases and 9.6 million cancer deaths in 2018 [Internet]. International Agency for Research on Cancer; 2018. Disponible en: https://www.uicc.org/new-global-cancer-data-globocan-2018
3. Organización Panamericana de la Salud. Carga mundial de cáncer alcanza a 14,1 millones de nuevos casos en 2012, según datos de IARC [Internet]. Organización Panamericana de la Salud [citado 2020 abr. 25]. Disponible en: https://www.paho.org/hq/index.php?option=com_content&view=article&id=9246:2013-global-cancer-burden-rises-14-1-million-new-cases-2012-iarc&Itemid=135&lang=es
4. Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018;68(6):394-424.
5. Barón F. Supervivientes al cáncer en España: situación actual. En: Brozos VE, Vazquez RF, Cueva BJ, Barón DFJ, editores. Monográfico SEOM de Largos Supervivientes en Cáncer [Internet]. Sociedad Española de Oncología Médica; 2013. p. 7-15. Disponible en: https://seom.org/seomcms/images/stories/recursos/infopublico/publicaciones/MONOGRAFICO_SEOM_LARGOS_SUPERVIVIENTES_I.pdf
6. Chacón M, Manghino L, Nadal J, Losco F. Calidad de vida y capacidad de desempeño en pacientes con cáncer de mama y pacientes con tumores del estroma gastrointetinal. Oncol Clínica. 2018;23(2):46-58.
7. Sawada NO, Nicolussi AC, De Paula JM, Garcia-Caro MP, Marti-Garcia C, Cruz-Quintana F. Qualidade de vida de pacientes brasileiros e espanhóis com câncer em tratamento quimioterápico: Revisão integrativa da literature. Rev Lat Am Enfermagem. 2016;24:e2688.
8. Nayak M, George A, Vidyasagar M, Mathew S, Nayak S, Nayak B, et al. Symptoms experienced by cancer patients and barriers to symptom management. Indian J Palliat Care [Internet]. 2015;21(3):349-54. Disponible en: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4617044/
9. Wakeda T, Okamura T, Kawahara T, Heike Y. Camouflage makeup improves quality of life in cancer patients with treatment-related skin changes. Tumori J. 2019;106(2):95-100.
10. Albaugh JA, Sufrin N, Lapin BR, Petkewicz J, Tenfelde S. Life after prostate cancer treatment: A mixed methods study of the experiences of men with sexual dysfunction and their partners. BMC Urol. 2017;17(1):1-9.
11. Wang PM, Hsu CW, Liu CT, Lai TY, Tzeng FL, Huang CF. Effect of acupressure on constipation in patients with advanced cancer. Support Care Cancer. 2019;27(9):3473-8.
12. Von Ah D. Cognitive changes associated with cancer and cancer treatment: State of the science. Clin J Oncol Nurs. 2015;19(1):47-56.
13. Faiman B. Diarrhea in multiple myeloma: A review of the literature. Clin J Oncol Nurs. 2016;20(4):E100-5.
14. Bisanz A, Tucker AM, Amin DM, Patel D, Calderon BB, Joseph MM, et al. Summary of the causative and treatment factors of diarrhea and the use of a diarrhea assessment and treatment tool to improve patient outcomes. Gastroenterol Nurs. 2010;33(4):268-81.
15. Chiang TY, Hsu HC, Jane SW, Chen SC. EGFRI-associated health-related quality of life by severity of skin toxicity in metastatic colorectal cancer patients receiving epidermal growth factor receptor inhibitor target therapy. Support Care Cancer. 2020;28:4771-9.
16. Chan JC, Lee YH, Liu CY, Shih HH, Tsay PK, Tang WR. A correlational study of skin toxicity and quality of life in patients with advanced lung cancer receiving targeted therapy. J Nurs Res. 2019;27(6):e51.
17. Pirschel C. The crucial role of symptom management in cancer care [Internet]. ONS VOICE; 2017 [citado 2020 ag. 24]. Disponible en: https://voice.ons.org/news-and-views/the-crucial-role-of-symptom-management-in-cancer-care
18. Ke YT, Kuo CC. Effects of colloidal oatmeal lotion on symptoms of dermatologic toxicities induced by epidermal growth factor receptor inhibitors. Adv Ski Wound Care. 2017;30(1):27-34.
19. Haruna F, Lipsett A, Marignol L. Topical management of acute radiation dermatitis in breast cancer patients: A systematic review and meta-analysis. Anticancer Res. 2017;37(10):5343-53.
20. Singh M, Alavi A, Wong R, Akita S. Radiodermatitis: A review of our current understanding. Am J Clin Dermatol. 2016;17(3):277-92.
21. McQuade RM, Stojanovska V, Abalo R, Bornstein JC, Nurgali K. Chemotherapy-induced constipation and diarrhea: Pathophysiology, current and emerging treatments. Front Pharmacol. 2016;7(414):1-14.
22. Koselke E, Kraft S. Chemotherapy-induced diarrhea: Options for treatment and prevention. J Hematol Oncol Pharm. 2012;2(4):143-51.
23. Benson AB, Ajani JA, Catalano RB, Engelking C, Kornblau SM, Martenson JA, et al. Recommended guidelines for the treatment of cancer treatment-induced diarrhea. J Clin Oncol. 2004;22(14):2918-26.
24. Burkett VS, Cleeland CS. Symptom burden in cancer survivorship. J Cancer Surviv. 2007;1(2):167-75.
25. Arrieta Ó, Angulo LP, Núñez-Valencia C, Dorantes-Gallareta Y, Macedo EO, Martínez-López D, et al. Association of depression and anxiety on quality of life, treatment adherence, and prognosis in patients with advanced non-small cell lung cancer. Ann Surg Oncol. 2013;20(6):1941-8.
26. Irarrázaval ME, Kleinman P, Silva RF, González LF, Torres C, Fritis M, et al. Calidad de vida en pacientes chilenas sobrevivientes de cáncer de mama. Rev Med Chil. 2016;144(12):1567-76.
27. So WKW, Cummings GG, de Calvo LEA, Day SW, Houlahan K, Nevidjon BM, et al. Enhancement of oncology nursing education in low- and middle-income countries: Challenges and strategies. J Cancer Policy [Internet]. 2016;8:10-6. Disponible en: http://dx.doi.org/10.1016/j.jcpo.2016.03.002
28. Liberati A, Altman DG, Tetzlaff J, Mulrow C, Gøtzsche PC, Ioannidis JPA, et al. The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate healthcare interventions: explanation and elaboration. BMJ [Internet]. 2009;339:b2700. Disponible en: https://www.bmj.com/content/339/bmj.b2700.full?view=long&pmid=19622552
29. Cruz FOAM, Vilela RA, Ferreira EB, Melo NS, Reis PED Dos. Evidence on the use of mobile apps during the treatment of breast cancer: Systematic review. JMIR mHealth uHealth. 2019;7(8):e13245.
30. Sundberg K, Wengström Y, Blomberg K, Hälleberg-Nyman M, Frank C, Langius-Eklöf A. Early detection and management of symptoms using an interactive smartphone application (Interaktor) during radiotherapy for prostate cancer. Support Care Cancer. 2017;25(7):2195-204.
31. Zhou K, Li J, Li X. Effects of cyclic adjustment training delivered via a mobile device on psychological resilience, depression, and anxiety in Chinese post-surgical breast cancer patients. Breast Cancer Res Treat. 2019;178(1):95-103.
32. Suh SR, Lee MK. Effects of nurse-led telephone-based supportive interventions for patients with cancer: A meta-analysis. Oncol Nurs Forum. 2017;44(4):E168-84.
33. Hintistan S, Nural N, Cilingir D, Gursoy A. Therapeutic effects of nurse telephone follow-up for lung cancer patients in Turkey. Cancer Nurs. 2017;40(6):508-16.
34. Mooney KH, Beck SL, Wong B, Dunson W, Wujcik D, Whisenant M, et al. Automated home monitoring and management of patient-reported symptoms during chemotherapy: results of the symptom care at home RCT. Cancer Med. 2017;6(3):537-46.
35. Lahart I, Metsios G, Nevill A, Carmichael A. Physical activity for women diagnosed with breast cancer after adjuvant therapy (Review). Cochrane Database Syst Rev. 2018;(1):CD011292.
36. Backman M, Browall M, Sundberg CJ, Wengström Y. Experiencing health - Physical activity during adjuvant chemotherapy treatment for women with breast cancer. Eur J Oncol Nurs. 2016;21:160-7.
37. Lin YY, Rau KM, Lin CC. Longitudinal study on the impact of physical activity on the symptoms of lung cancer survivors. Support Care Cancer. 2015;23(12):3545-53.
38. Coolbrandt A, Wildiers H, Laenen A, Aertgeerts B, De Casterlé BD, Van Achterberg T, et al. A nursing intervention for reducing symptom burden during chemotherapy. Oncol Nurs Forum. 2018;45(1):115-28.
39. Hagan TL, Arida JA, Hughes SH, Donovan HS. Creating individualized symptom management goals and strategies for cancer-related fatigue for patients with recurrent ovarian cancer. Cancer Nurs. 2017;40(4):305-13.
40. Van Der Meulen IC, May AM, De Leeuw JRJ, Koole R, Oosterom M, Hordijk GJ, et al. Long-term effect of a nurse-led psychosocial intervention on health-related quality of life in patients with head and neck cancer: A randomised controlled trial. Br J Cancer [Internet]. 2014;110(3):593-601. Disponible en: http://dx.doi.org/10.1038/bjc.2013.733
41. Tofthagen C, Boses S, Healy G, Jooma N. Evaluation of group acupuncture for cancer-related symptoms: a retrospective analysis. J Palliat Med. 2015;18(10):878-80.
42. Johns SA, Brown LF, Beck-Coon K, Talib TL, Monahan PO, Giesler RB, et al. Randomized controlled pilot trial of mindfulness-based stress reduction compared to psychoeducational support for persistently fatigued breast and colorectal cancer survivors. Support Care Cancer [Internet]. 2016;24(10):4085-96. Disponible en: http://dx.doi.org/10.1007/s00520-016-3220-4
43. Bilgiç Ş, Acaroğlu R. Effects of listening to music on the comfort of chemotherapy patients. West J Nurs Res. 2017;39(6):745-62.
44. Yildrim M, Gulsoy H, Ozgat C, Yesilbursali G, Aydin R. The effects of self-affirmation on chemotherapy-related symptoms. Essentials Palliat Care. 2013;21(1):107-35.
45. Fernández-Castro M, Martín-Gil B, Peña-García I, López-Vallecillo M, García-Puig ME. Effectiveness of semi-permeable dressings to treat radiation–induced skin reactions. A systematic review. Eur J Cancer Care (Engl). 2017;26(6):1-8.
46. National Cancer Institute. Complementary and alternative medicine [Internet]. Cancer Treatment; 2019 [citado 2020 abr. 28]. Disponible en: https://www.cancer.gov/about-cancer/treatment/cam
47. Dodd M, Janson S, Facione N, Faucett J, Froelicher ES, Humphreys J, et al. Advancing the science of symptom management. J Adv Nurs. 2001;33(5):668-76.
48. The University of California San Francisco, School of Nursing Symptom Management Faculty Group. A model for symptom management. J Nurs Scholarsh [Internet]. 1994;26(4):272-6. Disponible en: https://sigmapubs.onlinelibrary.wiley.com/doi/epdf/10.1111/j.1547-5069.1994.tb00333.x
49. Krzyzanowska MK, Julian JA, Powis M, Howell D, Earle CC, Enright KA, et al. Ambulatory Toxicity Management (AToM) in patients receiving adjuvant or neo-adjuvant chemotherapy for early stage breast cancer - a pragmatic cluster randomized trial protocol. BMC Cancer. 2019;19(1):884-94.
50. Barcenas CH, Niu J, Zhang N, Zhang Y, Buchholz TA, Elting LS, et al. Risk of hospitalization according to chemotherapy regimen in early-stage breast cancer. J Clin Oncol. 2014;32(19):2010-7.
51. Basch E, Deal AM, Dueck AC, Scher HI, Kris MG, Hudis C, et al. Overall survival results of a trial assessing patient-reported outcomes for symptom monitoring during routine cancer treatment. JAMA. 2017;318(2):197-8.
52. Prince RM, Powis M, Zer A, Atenafu EG, Krzyzanowska MK. Hospitalisations and emergency department visits in cancer patients receiving systemic therapy: Systematic review and meta-analysis. Eur J Cancer Care (Engl). 2019;28(1):1-11.
53. Haryani H, Fetzer SJ, Wy Cl, Hsu YY. Chemotherapy-induced peripheral neuropathy assessment tools: a systematic review. Oncol Nurs Forum. 2017; 44(3):111-23
54. Yoshida Y, Satoh A, Yamada T, Aisu N, Matsuoka T, Koganemaru T, et al. The relationship between evaluation methods for chemotherapy-induced peripheral neuropathy. Sci Rep. 2019;9(1):2036. Disponible en: https://doi.org/10.1034/s41598-019-56969-9.
Creative Commons License
Esta obra está bajo licencia internacional Creative Commons Reconocimiento-NoComercial-CompartirIgual 4.0.

Descargas

La descarga de datos todavía no está disponible.